CBD Unlimited is quickly rising to become the highest quality known brand in CBD.
Cave Creek, AZ, Nov. 17, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Endexx Corporation, (OTC: EDXC) (the “Company” or a/k/a “CBD Unlimited”), a lifestyle company focused on the intersection of science, compliance, and formulation of innovative phytonutrient-based food and nutritional products, is pleased to share that it has recently been garnering press and attention for its high-quality brand of products. Some recent examples include:
- Edge Media: Edge Media Network has recently published two articles about CBD Unlimited highlighting both the high quality as well as guidance to using CBD products featuring our CEO, Todd Davis:
https://www.edgemedianetwork.com/story.php?ch=health_fitness&sc=health&id=298874&how_much_is_enough and;
More can be found by searching “CBD Unlimited” on the web. With so much recent news and development in the cannabis world, CBD is becoming a major worldwide highlight as more states and countries continue to legalize cannabis in all forms.
CBD Unlimited has quickly become a name brand for trusted quality products found in over 6,000 retail stores and growing.
CBD Unlimited is part of the publicly-traded company, Endexx. Endexx CEO and Chairman, Todd Davis, commented, “We would like to thank our current shareholders for their continued support as the Company has been able to flourish over the years. We are excited for the future of CBD Unlimited and appreciate the recent third party attention and positive reviews our products have received.”
About Endexx Corporation and CBD Unlimited
Endexx Corporation, through its operating subsidiary CBD Unlimited, Inc., develops and distributes all-natural CBD products derived from Cannabis Sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab work in order to protect the accuracy in dosage and delivery of absorption per each serving.
Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors, or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions, and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.
Contact:
For further investor and media information, please contact:
Endexx Corporation
Todd Davis, Chairman, and CEO
480-595-6900
